It has been reported that individuals with T2D, obesity, or both have increased levels of IGF-1[45–47] and that IGF-1 induced MUC5B expression is regulated by activation of p38 MAPK[44]. The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.